183 related articles for article (PubMed ID: 15658951)
1. The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers.
Petersen KA; Birk S; Lassen LH; Kruuse C; Jonassen O; Lesko L; Olesen J
Cephalalgia; 2005 Feb; 25(2):139-47. PubMed ID: 15658951
[TBL] [Abstract][Full Text] [Related]
2. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation.
Petersen KA; Lassen LH; Birk S; Lesko L; Olesen J
Clin Pharmacol Ther; 2005 Mar; 77(3):202-13. PubMed ID: 15735614
[TBL] [Abstract][Full Text] [Related]
3. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats.
Arulmani U; Schuijt MP; Heiligers JP; Willems EW; Villalón CM; Saxena PR
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):291-7. PubMed ID: 15228501
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat.
Petersen KA; Birk S; Doods H; Edvinsson L; Olesen J
Br J Pharmacol; 2004 Nov; 143(6):697-704. PubMed ID: 15504760
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
[TBL] [Abstract][Full Text] [Related]
6. Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients.
Lassen LH; Jacobsen VB; Haderslev PA; Sperling B; Iversen HK; Olesen J; Tfelt-Hansen P
J Headache Pain; 2008 Jun; 9(3):151-7. PubMed ID: 18437288
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.
Doods H; Hallermayer G; Wu D; Entzeroth M; Rudolf K; Engel W; Eberlein W
Br J Pharmacol; 2000 Feb; 129(3):420-3. PubMed ID: 10711339
[TBL] [Abstract][Full Text] [Related]
8. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig.
Kapoor K; Arulmani U; Heiligers JP; Willems EW; Doods H; Villalón CM; Saxena PR
Eur J Pharmacol; 2003 Aug; 475(1-3):69-77. PubMed ID: 12954361
[TBL] [Abstract][Full Text] [Related]
9. BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37).
Verheggen R; Bumann K; Kaumann AJ
Br J Pharmacol; 2002 May; 136(1):120-6. PubMed ID: 11976276
[TBL] [Abstract][Full Text] [Related]
10. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow.
Tröltzsch M; Denekas T; Messlinger K
Eur J Pharmacol; 2007 May; 562(1-2):103-10. PubMed ID: 17349622
[TBL] [Abstract][Full Text] [Related]
11. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.
Edvinsson L; Alm R; Shaw D; Rutledge RZ; Koblan KS; Longmore J; Kane SA
Eur J Pharmacol; 2002 Jan; 434(1-2):49-53. PubMed ID: 11755165
[TBL] [Abstract][Full Text] [Related]
12. BIBN4096BS and CGRP(8-37) antagonize the relaxant effects of alpha-CGRP more than those of beta-CGRP in human extracranial arteries.
Verheggen R; Wojtas K; Webel M; Hoffmann S; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):383-92. PubMed ID: 15983761
[TBL] [Abstract][Full Text] [Related]
13. Clinical data on the CGRP antagonist BIBN4096BS for treatment of migraine attacks.
Edvinsson L
CNS Drug Rev; 2005; 11(1):69-76. PubMed ID: 15867953
[TBL] [Abstract][Full Text] [Related]
14. Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries.
Sheykhzade M; Lind H; Edvinsson L
Br J Pharmacol; 2004 Dec; 143(8):1066-73. PubMed ID: 15477223
[TBL] [Abstract][Full Text] [Related]
15. Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs.
Kapoor K; Arulmani U; Heiligers JP; Garrelds IM; Willems EW; Doods H; Villalón CM; Saxena PR
Br J Pharmacol; 2003 Sep; 140(2):329-38. PubMed ID: 12970078
[TBL] [Abstract][Full Text] [Related]
16. The preclinical pharmacology of BIBN4096BS, a CGRP antagonist.
Hay DL; Poyner D
Cardiovasc Drug Rev; 2005; 23(1):31-42. PubMed ID: 15867946
[TBL] [Abstract][Full Text] [Related]
17. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.
Hay DL; Christopoulos G; Christopoulos A; Sexton PM
Mol Pharmacol; 2006 Dec; 70(6):1984-91. PubMed ID: 16959943
[TBL] [Abstract][Full Text] [Related]
18. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS.
Schindler M; Doods HN
Eur J Pharmacol; 2002 May; 442(3):187-93. PubMed ID: 12065071
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin gene-related peptide (CGRP) antagonists: blockers of neuronal transmission in migraine.
Brain SD
Br J Pharmacol; 2004 Aug; 142(7):1053-4. PubMed ID: 15237096
[TBL] [Abstract][Full Text] [Related]
20. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS blocks CGRP and adrenomedullin vasoactive responses in the microvasculature.
Grant AD; Tam CW; Lazar Z; Shih MK; Brain SD
Br J Pharmacol; 2004 Aug; 142(7):1091-8. PubMed ID: 15237099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
